517 related articles for article (PubMed ID: 20530699)
61. GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition.
Arai MA; Ochi F; Makita Y; Chiba T; Higashi K; Suganami A; Tamura Y; Toida T; Iwama A; Sadhu SK; Ahmed F; Ishibashi M
ACS Chem Biol; 2018 Sep; 13(9):2551-2559. PubMed ID: 30160475
[TBL] [Abstract][Full Text] [Related]
62. Hedgehog Signaling Pathway and Autophagy in Cancer.
Zeng X; Ju D
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081498
[TBL] [Abstract][Full Text] [Related]
63. Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
Bai XY; Zhang XC; Yang SQ; An SJ; Chen ZH; Su J; Xie Z; Gou LY; Wu YL
PLoS One; 2016; 11(3):e0149370. PubMed ID: 26943330
[TBL] [Abstract][Full Text] [Related]
64. Regulation of Hedgehog Signaling in Cancer by Natural and Dietary Compounds.
Bao C; Kramata P; Lee HJ; Suh N
Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 29164817
[TBL] [Abstract][Full Text] [Related]
65. The Hedgehog signaling pathway--implications for drug targets in cancer and neurodegenerative disorders.
Bak M; Hansen C; Tommerup N; Larsen LA
Pharmacogenomics; 2003 Jul; 4(4):411-29. PubMed ID: 12831321
[TBL] [Abstract][Full Text] [Related]
66. Hedgehog Signaling and Truncated GLI1 in Cancer.
Doheny D; Manore SG; Wong GL; Lo HW
Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
[TBL] [Abstract][Full Text] [Related]
67. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis.
Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S
J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819
[TBL] [Abstract][Full Text] [Related]
68. Design and biological evaluation of phenyl imidazole analogs as hedgehog signaling pathway inhibitors.
Sun C; Zhang Y; Wang H; Yin Z; Wu L; Huang Y; Zhang W; Wang Y; Hu Q
Chem Biol Drug Des; 2021 Mar; 97(3):546-552. PubMed ID: 32946174
[TBL] [Abstract][Full Text] [Related]
69. Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth.
Campbell VT; Nadesan P; Ali SA; Wang CY; Whetstone H; Poon R; Wei Q; Keilty J; Proctor J; Wang LW; Apte SS; McGovern K; Alman BA; Wunder JS
Mol Cancer Ther; 2014 May; 13(5):1259-69. PubMed ID: 24634412
[TBL] [Abstract][Full Text] [Related]
70. Targeting the Hedgehog pathway in cancer: can the spines be smoothened?
Ailles L; Siu LL
Clin Cancer Res; 2011 Apr; 17(8):2071-3. PubMed ID: 21367749
[TBL] [Abstract][Full Text] [Related]
71. Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway.
Alfonsi R; Botta B; Cacchi S; Di Marcotullio L; Fabrizi G; Faedda R; Goggiamani A; Iazzetti A; Mori M
J Med Chem; 2017 Feb; 60(4):1469-1477. PubMed ID: 28122186
[TBL] [Abstract][Full Text] [Related]
72. Drugging the cancer stem cell compartment: lessons learned from the hedgehog and Wnt signal transduction pathways.
Dodge ME; Lum L
Annu Rev Pharmacol Toxicol; 2011; 51():289-310. PubMed ID: 20887197
[TBL] [Abstract][Full Text] [Related]
73. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.
Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S
Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983
[TBL] [Abstract][Full Text] [Related]
74. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
75. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E
BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052
[TBL] [Abstract][Full Text] [Related]
76. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade.
Hyman JM; Firestone AJ; Heine VM; Zhao Y; Ocasio CA; Han K; Sun M; Rack PG; Sinha S; Wu JJ; Solow-Cordero DE; Jiang J; Rowitch DH; Chen JK
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):14132-7. PubMed ID: 19666565
[TBL] [Abstract][Full Text] [Related]
77. Nonclassical hedgehog-GLI signaling and its clinical implications.
Shevde LA; Samant RS
Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
[TBL] [Abstract][Full Text] [Related]
78. Discovery of novel 4-(2-pyrimidinylamino)benzamide derivatives as highly potent and orally available hedgehog signaling pathway inhibitors.
Xin M; Zhang L; Jin Q; Tang F; Wen J; Gu L; Cheng L; Zhao Y
Eur J Med Chem; 2016 Mar; 110():115-25. PubMed ID: 26820554
[TBL] [Abstract][Full Text] [Related]
79. The Hedgehog pathway: role in cell differentiation, polarity and proliferation.
Jia Y; Wang Y; Xie J
Arch Toxicol; 2015 Feb; 89(2):179-91. PubMed ID: 25559776
[TBL] [Abstract][Full Text] [Related]
80. Hedgehog signalling as a target in cancer stem cells.
Medina V; Calvo MB; Díaz-Prado S; Espada J
Clin Transl Oncol; 2009 Apr; 11(4):199-207. PubMed ID: 19380296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
